Krilogy Financial’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History
Bought
Maintained
Sold
Other funds holding BTAL
PPW
FDCDDQ
CCA
AWM
OIA
CGA
Krilogy Financial's BTAL Position: Q1 2026 in Review
Krilogy Financial increased its AGF US Market Neutral Anti-Beta Fund (BTAL) stake by 32% in Q1 2026, buying an estimated $2.01M and bringing the position to 597,562 shares worth $7.68M. The position accounts for 0.25% of the portfolio, ranked #71.
Krilogy Financial first reported a position in BTAL in Q3 2025 and has held it in 3 quarters since. 87 funds tracked by Wall St. Rank hold BTAL as of Q1 2026.
- Krilogy Financial held 597,562 shares of AGF US Market Neutral Anti-Beta Fund worth $7.68M as of Q1 2026.
- Krilogy Financial bought 143,661 AGF US Market Neutral Anti-Beta Fund shares in Q1 2026, an estimated $2.01M.
- AGF US Market Neutral Anti-Beta Fund made up 0.25% of Krilogy Financial's portfolio in Q1 2026, its #71 holding.
- Krilogy Financial first reported a position in AGF US Market Neutral Anti-Beta Fund in Q3 2025 and has held it in 3 quarters since.
- 87 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q1 2026.
Based on Krilogy Financial's 13F filing for Q1 2026, filed 17 Apr 2026.